Evoq Remedies Limited (EVOQ.BO)
INR 8.37
(5.28%)
INR 8.37
(5.28%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 53.19 Million | -43.45 Million | -276.37 Million | 311.26 Thousand | -214 Thousand | 63 Thousand |
| Net Income | 4.52 Million | 16.19 Million | 10.91 Million | 7.15 Million | 3000.00 | 111 Thousand |
| Depreciation & Amortization | 72.97 Thousand | 39 Thousand | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 10.4 Million | -42.23 Million | -219.46 Million | -18.43 Million | -35.26 Million | -21.23 Million |
| Other non-cash items | 38.19 Million | -17.45 Million | -67.82 Million | 11.59 Million | 35.04 Million | 21.18 Million |
| Investing Cash Flow | -120 Thousand | -131 Thousand | - | - | - | - |
| Investments in PPE | -120 Thousand | -131 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -53.38 Million | 14.18 Million | 294.89 Million | - | 48 Thousand | 12 Thousand |
| Debt repayment | - | -14.18 Million | - | - | -48 Thousand | -12 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -53.38 Million | - | 294.89 Million | - | - | - |
| Accounts receivables | 154.72 Million | 81.81 Million | -185.61 Million | -21.18 Million | -34.89 Million | -12.28 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -10.92 Million | -12.47 Million | -6.33 Million | -900.86 Thousand | -306 Thousand | -300 Thousand |
| Other working capital | -133.39 Million | -111.57 Million | -27.51 Million | 3.64 Million | -57 Thousand | -8.65 Million |
| Cash at beginning of period | 1.53 Million | 18.85 Million | 333.44 Thousand | 22 Thousand | 188 Thousand | 113 Thousand |
| Cash at end of period | 1.23 Million | 1.53 Million | 18.85 Million | 333.44 Thousand | 22 Thousand | 188 Thousand |
| Capital Expenditure | -120 Thousand | -131 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -302 Thousand | -17.31 Million | 18.52 Million | 311.44 Thousand | -166 Thousand | 75 Thousand |
| Free Cash Flow | 53.07 Million | -43.58 Million | -276.37 Million | 311.26 Thousand | -214 Thousand | 63 Thousand |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.52 Million | 2.01 Million | 2.01 Million | 250 Thousand | 250 Thousand | 16.19 Million |
| Depreciation & Amortization | 73 Thousand | 13.98 Thousand | 14 Thousand | 22.5 Thousand | 22.5 Thousand | 39 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 10.4 Million | -15.91 Million | -15.91 Million | 21.11 Million | 21.11 Million | -42.23 Million |
| Other non-cash items | 38.19 Million | -596 Thousand | -596 Thousand | 19.69 Million | 19.69 Million | -17.45 Million |
| Investing Cash Flow | -120 Thousand | 5500.00 | 5500.00 | -65.5 Thousand | -65.5 Thousand | -131 Thousand |
| Investments in PPE | -120 Thousand | 5500.00 | 5500.00 | -65.5 Thousand | -65.5 Thousand | -131 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -53.38 Million | 14.81 Million | 14.81 Million | -41.5 Million | -41.5 Million | 14.18 Million |
| Debt repayment | - | - | - | - | - | -14.18 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -53.38 Million | 14.81 Million | 14.81 Million | -41.5 Million | -41.5 Million | - |
| Accounts receivables | 154.72 Million | 46.97 Million | 46.97 Million | 30.39 Million | 30.39 Million | 81.81 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -10.92 Million | -7.82 Million | -7.82 Million | 2.36 Million | 2.36 Million | -12.47 Million |
| Other working capital | -133.39 Million | -55.05 Million | -55.05 Million | -11.64 Million | -11.64 Million | -111.57 Million |
| Cash at beginning of period | 1.53 Million | 12.00 | - | - | - | 18.85 Million |
| Cash at end of period | 1.23 Million | 333.5 Thousand | 333.5 Thousand | -484.5 Thousand | -484.5 Thousand | 1.53 Million |
| Capital Expenditure | -120 Thousand | 5500.00 | 5500.00 | -65.5 Thousand | -65.5 Thousand | -131 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -302 Thousand | 333.48 Thousand | 333.5 Thousand | -484.5 Thousand | -484.5 Thousand | -17.31 Million |
| Free Cash Flow | 53.07 Million | -14.47 Million | -14.47 Million | 41.01 Million | 41.01 Million | -43.58 Million |
FISK
KSKGF
ARTMS
MLEDU
688595
CCSI